Cerebellum’s NxStage Medical Inc. NXTM Stock Holding History

Cerebellum’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,969	Closed	-$48K	–	649
2020 Q2	$48K	Buy	+1,969	New	+$48K	0.03%	418
2018 Q1	–	Sell	-1,969	Closed	-$48K	–	569
2017 Q4	$48K	Buy	+1,969	New	+$51.9K	0.03%	418

Cerebellum's NXTM Position: Q3 2020 in Review

Cerebellum sold out of NxStage Medical Inc. (NXTM) in Q3 2020, closing a stake of 1,969 shares — an estimated $48K sold.

Cerebellum first reported a position in NXTM in Q4 2017 and held it in 2 quarters. The position peaked at $48K in Q2 2020. 1 fund tracked by Wall St. Rank holds NXTM as of Q3 2020.

Cerebellum reported no remaining NxStage Medical Inc. position as of Q3 2020 after selling out during the quarter.
Cerebellum sold 1,969 NxStage Medical Inc. shares in Q3 2020, an estimated $48K.
Cerebellum first reported a position in NxStage Medical Inc. in Q4 2017 and held it in 2 quarters.
Cerebellum's NxStage Medical Inc. position peaked at $48K in Q2 2020.
1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2020.

Based on Cerebellum's 13F filing for Q3 2020, filed 21 Oct 2020.